Sakai, Japan

Shun-ichi Ikeda

This inventor holds 9 USPTO granted patents. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Other. Active years: 1987-2005.


% Patents Active = 66.7

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Numazu, JP (1996)
  • Osaka, JP (1999 - 2003)
  • Sakai, JP (1987 - 2004)
  • Machida, JP (2005)

Company Filing History:


Years Active: 1987-2005

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Shun-ichi Ikeda: Innovator in Antitumor and Antibacterial Research

Introduction

Shun-ichi Ikeda is a notable inventor based in Sakai, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor and antibacterial properties. With a total of nine patents to his name, Ikeda's work has the potential to impact medical treatments significantly.

Latest Patents

Among his latest innovations are the UCS1025 derivatives, which exhibit antitumor and antibacterial activity. These derivatives are represented by a complex formula that includes various functional groups, showcasing Ikeda's expertise in chemical synthesis and medicinal chemistry. Additionally, he has developed LK6-A derivatives, further expanding his portfolio of innovative compounds.

Career Highlights

Ikeda has worked with prominent companies in the pharmaceutical industry, including Kyowa Hakko Kogyo Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Ikeda has collaborated with esteemed colleagues, including Yutaka Kanda and Tsutomu Akama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Shun-ichi Ikeda's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, particularly in combating diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…